While all Kaiser Permanente Northern California hospitals are Primary Stroke Care centers, the Redwood City Hospital is now a Comprehensive Stroke Care Center, due to its specialized capabilities in neurological disease.
Already a leader in minimally invasive surgery for gynecologic cancers, Kaiser Permanente Northern California has enhanced its care with the addition of robotic technology. Above, [...]
The Permanente Medical Group uses advanced technology to guide prescribing practice and maximize the impact of effective antibiotic use of commonly over-treated conditions.
10 Kaiser Permanente hospitals in Northern California were rated high performing by the U.S. News & World Report Best Hospitals for Common Care.
TPMG y La Universidad de California, lanzaron hoy un nuevo proyecto en la Facultad de Medicina UC Davis, que tiene por objeto preparar a la próxima generación de médicos abocados a la promoción de la salud de los latinos.
TPMG and UC Davis are launching a new initiative at UC Davis School of Medicine dedicated to building the next generation of physicians committed to advancing Latino health.
Dr. Morris F. Collen, a founding partner of The Permanente Medical Group who, until recently, worked part time at Kaiser Permanente's Division of Research, died on September 27, 2014, of cancer. He was 100.
Eight Kaiser Permanente hospitals in Northern California are rated “high performing,” according to U.S. News and World Reports’ 2014-15 Best Hospitals in America rankings.
Dermatologists tend to prescribe more expensive medications when they also give their patients drug samples, according to a new study from the Stanford University School of Medicine. Kenneth Katz, MD, a TPMG dermatologist, published an editorial pointing out that Kaiser Permanente bans drug sampling and other conflicts of interest related to the pharmaceutical industry.
Kaiser Permanente said it is using Gilead Sciences’ new, breakthrough hepatitis C drug, Sovaldi, even though its $84,000 treatment price is exorbitant. “It’s an outrageous price for a therapy that has huge public health implications, ” said Sharon Levine, MD, associate director of The Permanente Medical Group.
